| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/15/1998 | EP0835253A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | EP0835126A1 Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/15/1998 | EP0835117A1 Ether derivatives of pseudopterosin |
| 04/15/1998 | EP0797442A4 Treatment of optic neuritis |
| 04/15/1998 | EP0650367A4 Blocking intercellular interactions with cd43 chimeric molecules. |
| 04/15/1998 | EP0460052B1 Il-1 biological activity inhibitors |
| 04/14/1998 | US5739351 Neurokinin a antagonists |
| 04/14/1998 | US5739322 Process for preparing BIS-indolyl macrocycles |
| 04/14/1998 | US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/14/1998 | US5739282 Amino acid sequence and dna |
| 04/14/1998 | US5739279 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents |
| 04/14/1998 | US5739166 Alkylsulfonyl or aminosulfonyl substituted aromatic compounds as non-steroidal antiinflammatory agent |
| 04/14/1998 | US5739165 Reducing sugar-free mixture of ibuprofen and phenylpropanolamine; heat and storage stability, discoloration inhibition |
| 04/14/1998 | US5739157 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
| 04/14/1998 | US5739144 Trisubstituted phenyl derivatives |
| 04/14/1998 | US5739141 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739137 Enzyme inhibitor treating skin disorder, hair baldness, glandular disorder and prostatic hyperplasia |
| 04/14/1998 | US5739130 Treating systemic lupus erythematosis, melanoma |
| 04/14/1998 | US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014480A1 G protein-coupled receptor antagonists |
| 04/09/1998 | WO1998014454A2 (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES |
| 04/09/1998 | WO1998014432A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives |
| 04/09/1998 | WO1998014424A1 Hydroxamic acid derivatives |
| 04/09/1998 | WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | WO1998014192A1 Vitronectin receptor antagonists |
| 04/09/1998 | WO1998014186A1 Substances and their uses |
| 04/09/1998 | WO1998014174A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 04/09/1998 | CA2267950A1 (o-acyl-p-n-acylamino-phenyl)-o-phosphoethanolamines |
| 04/09/1998 | CA2267421A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | CA2267415A1 Hydroxamic acid derivatives |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0834510A2 Flavone derivative and medicine comprising the same |
| 04/08/1998 | EP0834508A1 Substituted biphenyl or phenylpyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/08/1998 | EP0834315A1 Use of an imidazole derivative for the manufacture of a medicament for preventing and/or treating rhinitis |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 04/08/1998 | EP0833892A1 Human hepatoma-derived growth factor-2 |
| 04/08/1998 | EP0833828A1 Rapamycin derivatives |
| 04/08/1998 | EP0833818A1 Cb 2? receptor agonist compounds |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833650A1 P-selectin ligands and related molecules and methods |
| 04/08/1998 | EP0833626A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0680488B1 2,6-diaminopurine derivatives |
| 04/08/1998 | EP0630405B1 Novel V28 seven transmembrane receptor |
| 04/08/1998 | EP0558681B1 Treatment for tissue ulceration |
| 04/08/1998 | CN1178118A External use disinfectant anagesic and production thereof |
| 04/08/1998 | CN1178106A Cyclosphorin-containing soft capsule preparation |
| 04/08/1998 | CN1037934C Pharmaceutical soft capsules containing lysne elonixiwate |
| 04/07/1998 | US5736570 Administering to reduce tumor necrosis factor (tnfa) levels in mammal; retroviral disease treatment/prophylaxis |
| 04/07/1998 | US5736568 2-(aminoalkoxy) phenylalkylamines with antiinflammatory activity |
| 04/07/1998 | US5736549 Hypoxanthine and guanine compounds |
| 04/07/1998 | US5736542 Pharmaceutical compositions containing a staurosporine |
| 04/07/1998 | US5736535 1-pyrimidinylacetamide compounds which are inhibitors of human leukocyte elastase |
| 04/07/1998 | US5736533 Inhibiting colonization of streptococcus pneumoniae, hemophilus influenza or parainfluenza, burkholderia (pseudomonas) cepacia by administering binding inhibiting oligosaccharide |
| 04/07/1998 | US5736522 Chondoprotective agent |
| 04/07/1998 | US5736507 Peptide of human cartilage glycoprotein 39, which stimulates autoreactive t-cells found in blood of rheumatoid arthritis patients |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5736337 Inhibiting protein interactions |
| 04/07/1998 | US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/07/1998 | CA2146259C Substituted benzylaminoquinuclidines |
| 04/07/1998 | CA2130116C Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/07/1998 | CA2084193C 3-amino-2-aryl quinuclidines |
| 04/07/1998 | CA2003441C Quinuclidine therapeutic agents |
| 04/07/1998 | CA1339802C Diarylstrylquinoline diacids |
| 04/02/1998 | WO1998013484A1 Two human cathepsin proteins |
| 04/02/1998 | WO1998013376A1 Inhibitors of pla¿2? |
| 04/02/1998 | WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 04/02/1998 | WO1998013366A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 04/02/1998 | WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 04/02/1998 | WO1998013347A1 Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | WO1998013062A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
| 04/02/1998 | WO1998013061A1 Inhibition of 26s and 20s proteasome by indanones |
| 04/02/1998 | WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | CA2658989A1 Tripterygium wilfordii preparations and uses thereof |
| 04/02/1998 | CA2266746A1 Inhibitors of pla2 |
| 04/02/1998 | CA2266419A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | CA2266098A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
| 04/02/1998 | CA2265996A1 Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| 04/02/1998 | CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/02/1998 | CA2264546A1 Two human cathepsin proteins |
| 04/01/1998 | EP0832886A1 Flavon derivatives, process for their preparation, and pharmaceutical compositions containing them |
| 04/01/1998 | EP0832652A1 Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832213A1 TNF-$g(a) RIBOZYMES, TNF-$g(a) RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832112A1 Monocyte chemotactic protein-4 |
| 04/01/1998 | EP0832099A1 Reversible cysteine protease inhibitors |
| 04/01/1998 | EP0832092A1 Orally active adenosine kinase inhibitors |
| 04/01/1998 | EP0832091A1 C-4' modified adenosine kinase inhibitors |